Arihant Capital is bullish on Marksans Pharma has recommended buy rating on the stock with a target price of Rs 80 in its research report dated August 19, 2022.
Arihant Capital is bullish on Marksans Pharma has recommended buy rating on the stock with a target price of Rs 80 in its research report dated August 19, 2022.